FORTEM FINANCIAL GROUP, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1766509 PALM DESERT, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$831,948

-$55,002 QoQ

Shares Held

6,585

+3.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#1,153

of 2,266 holders

Holding Since

Dec 2020

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FORTEM FINANCIAL GROUP, LLC holds $5,722,803 across 5 Drug Manufacturers - General names. GILD ranks #4 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,577	$1,891,501
2	ABBV	AbbVie Inc.	5,778	$1,453,975
3	JNJ	Johnson & Johnson	4,057	$1,030,356
4	GILD	Gilead Sciences, Inc. This page	6,585	$831,948
5	PFE	Pfizer Inc	21,388	$515,023

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$831,948	6,585	+3.5%	Shares	Sole	2026-07-20
2026-03-31	$886,950	6,364	+11.2%	Shares	Sole	2026-04-16
2025-12-31	$702,686	5,725	-5.0%	Shares	Sole	2026-02-04
2025-09-30	$669,108	6,028	-4.5%	Shares	Sole	2025-11-04
2025-06-30	$699,478	6,309	-1.8%	Shares	Sole	2025-08-12
2025-03-31	$719,809	6,424	-3.7%	Shares	Sole	2025-05-01
2024-12-31	$616,107	6,670	+6.5%	Shares	Sole	2025-01-06
2024-09-30	$525,089	6,263	-30.0%	Shares	Sole	2024-11-18
2024-06-30	$614,196	8,952	-5.7%	Shares	Sole	2024-08-02
2024-03-31	$695,582	9,496	+17.9%	Shares	Sole	2024-05-01
2023-12-31	$652,292	8,052	-1.0%	Shares	Sole	2024-02-13
2023-09-30	$609,711	8,136	-10.2%	Shares	Sole	2023-10-10
2023-06-30	$698,408	9,062	+10.7%	Shares	Sole	2023-07-18
2023-03-31	$679,358	8,188	-6.4%	Shares	Sole	2023-04-21
2022-12-31	$750,929	8,747	+0.2%	Shares	Sole	2023-01-17
2022-09-30	$538,306	8,726	-10.1%	Shares	Sole	2022-11-01
2022-06-30	$599,742	9,703	+15301.6%	Shares	Sole	2022-07-25
2020-12-31	$3,670	63	—	Shares	Sole	2021-01-29
No filing history on record for this holder in this stock.